Change search
ReferencesLink to record
Permanent link

Direct link
Time window of TNF-a in innate immunity against staphylococcal infection
University of Skövde, School of Life Sciences.
2010 (English)Independent thesis Basic level (degree of Bachelor), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

Staphylococcus aureus (S. aureus) is responsible for many human diseases including septic arthritis and sepsis shock. Tumor necrosis factor alpha (TNF-α) is a pro-inflammatory cytokine involved in inflammation and produced mainly by macrophages and monocytes. It is believed to be involved in pathogenesis of septic arthritis. Time window of TNF-a in innate immunity against staphylococcal infection was studied in this project.

Two experiments were carried out: In the first experiment mice were infected with a low dose (8x106cfu/mouse) of S. aureus to induce septic arthritis whereas in the second experiment the mice were infected with a higher dose (8x107cfu/mouse) of S. aureus to induce sepsis shock. All mice were divided into three groups. The first group was treated with anti-TNF-α 20 minutes after infection. The second group was treated with the anti-TNF-α three days after infection. The third group served as control and was injected with PBS instead of anti-TNF-α. The mice were regularly weighed and signs of arthritis and mortality were recorded. Two weeks after inoculation bacteria viable counts in different organs was done, as well as histopathological assessment of joints and measurement of cytokines in blood.

We have observed that mice treated with anti-TNF-α had less severe arthritis and also less mortality. However, they had more bacteria accumulated in the kidneys and lost more weight compared to the control group. The results were mostly seen in the group early treated with TNF-α, compared to the late treated group.

We conclude that anti-TNF-α might be potentially used as a therapy against septic arthritis and sepsis shock. This should be combined with antibiotics to eliminate the bacteria while the anti-TNF-α reduces the severity of the inflammation and thus reduce the risk of permanent joint destruction and mortality. We can conclude that blocking TNF-α early on is essential in order to get the best results.

Place, publisher, year, edition, pages
2010. , 19 p.
National Category
Rheumatology and Autoimmunity
Identifiers
URN: urn:nbn:se:his:diva-4897OAI: oai:DiVA.org:his-4897DiVA: diva2:418315
Subject / course
Biomedicine/Medical Science
Educational program
Biomedicine - Study Programme
Uppsok
Medicine
Supervisors
Examiners
Available from: 2011-05-28 Created: 2011-05-21 Last updated: 2011-05-28Bibliographically approved

Open Access in DiVA

fulltext(564 kB)358 downloads
File information
File name FULLTEXT01.pdfFile size 564 kBChecksum SHA-512
39963cb3d1f9d5ed731e654a4a6521db7ebb7628eb3ec5392a5f2be5369fc06b08515cec5b0f8bed87d0a91e5fc5d67611688e143fefeb50517ab5236afc4c9e
Type fulltextMimetype application/pdf

Search in DiVA

By author/editor
Ali, Abukar
By organisation
School of Life Sciences
Rheumatology and Autoimmunity

Search outside of DiVA

GoogleGoogle Scholar
Total: 358 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 201 hits
ReferencesLink to record
Permanent link

Direct link